Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Wells Fargo to hold a virtual conference » 04:55
04/08/21
04/08
04:55
04/08/21
04:55
ADAP

Adaptimmune

$4.96 /

-0.3 (-5.70%)

, AGTC

Applied Genetic

$4.45 /

-0.29 (-6.12%)

, BLCM

Bellicum Pharmaceuticals

$3.50 /

-0.12 (-3.31%)

, BEAM

Beam Therapeutics

$74.42 /

-2.26 (-2.95%)

, AVRO

Avrobio

$11.41 /

-0.3 (-2.56%)

, CLLS

Cellectis

$19.28 /

-0.53 (-2.68%)

, CCXI

ChemoCentryx

$48.00 /

-0.79 (-1.62%)

, CALA

Calithera Biosciences

$2.42 /

-0.065 (-2.62%)

, HALO

Halozyme

$42.36 /

-0.175 (-0.41%)

, IMV

IMV Inc.

$2.96 /

-0.235 (-7.36%)

, MORF

Morphic

$60.76 /

-0.6 (-0.98%)

, MRNA

Moderna

$131.52 /

-2 (-1.50%)

, PGEN

Precigen

$6.79 /

-0.24 (-3.41%)

, QURE

uniQure

$34.51 /

-1.41 (-3.93%)

, TCON

Tracon Pharmaceuticals

$8.78 /

-0.18 (-2.01%)

, STRO

Sutro Biopharma

$21.28 /

-1.6 (-6.99%)

, SGMO

Sangamo

$11.24 /

-0.61 (-5.15%)

, RNA

Avidity Biosciences

$23.58 /

-0.97 (-3.95%)

, RGLS

Regulus

$1.44 /

-0.04 (-2.70%)

, ZIOP

Ziopharm

$3.37 /

-0.045 (-1.32%)

Biotech Corporate Access…

Biotech Corporate Access Day Virtual Conference will be held on April 6-8.

ShowHide Related Items >><<
ZIOP Ziopharm
$3.37 /

-0.045 (-1.32%)

TCON Tracon Pharmaceuticals
$8.78 /

-0.18 (-2.01%)

STRO Sutro Biopharma
$21.28 /

-1.6 (-6.99%)

SGMO Sangamo
$11.24 /

-0.61 (-5.15%)

RNA Avidity Biosciences
$23.58 /

-0.97 (-3.95%)

RGLS Regulus
$1.44 /

-0.04 (-2.70%)

QURE uniQure
$34.51 /

-1.41 (-3.93%)

PGEN Precigen
$6.79 /

-0.24 (-3.41%)

MRNA Moderna
$131.52 /

-2 (-1.50%)

MORF Morphic
$60.76 /

-0.6 (-0.98%)

IMV IMV Inc.
$2.96 /

-0.235 (-7.36%)

HALO Halozyme
$42.36 /

-0.175 (-0.41%)

CLLS Cellectis
$19.28 /

-0.53 (-2.68%)

CCXI ChemoCentryx
$48.00 /

-0.79 (-1.62%)

CALA Calithera Biosciences
$2.42 /

-0.065 (-2.62%)

BLCM Bellicum Pharmaceuticals
$3.50 /

-0.12 (-3.31%)

BEAM Beam Therapeutics
$74.42 /

-2.26 (-2.95%)

AVRO Avrobio
$11.41 /

-0.3 (-2.56%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
BLCM Bellicum Pharmaceuticals
$3.50 /

-0.12 (-3.31%)

10/30/20
Fly Intel: Top five analyst downgrades
10/30/20 Ladenburg
Bellicum Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
10/30/20 Wells Fargo
Bellicum Pharmaceuticals downgraded to Equal Weight from Overweight at Wells Fargo
10/30/20 Wells Fargo
Bellicum downgraded to Equal Weight from Overweight at Wells Fargo
BEAM Beam Therapeutics
$74.42 /

-2.26 (-2.95%)

03/01/21 Barclays
Beam Therapeutics downgraded to Equal Weight from Overweight at Barclays
02/25/21 Wedbush
Beam Therapeutics price target raised to $112 from $42 at Wedbush
02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Wells Fargo
Beam Therapeutics initiated with an Overweight at Wells Fargo
AVRO Avrobio
$11.41 /

-0.3 (-2.56%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/09/21 Barclays
Avrobio initiated with an Overweight at Barclays
03/01/21 Stifel
Avrobio initiated with a Hold at Stifel
02/17/21 Mizuho
Avrobio selloff on Bluebird news a buying opportunity, says Mizuho
CLLS Cellectis
$19.28 /

-0.53 (-2.68%)

03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral from Outperform at Baird
08/19/20
Fly Intel: Top five analyst upgrades
CCXI ChemoCentryx
$48.00 /

-0.79 (-1.62%)

03/26/21 Piper Sandler
ChemoCentryx given FDA panel meeting on May 6, says Piper Sandler
03/02/21 H.C. Wainwright
ChemoCentryx price target raised to $101 from $83 at H.C. Wainwright
03/01/21 Stifel
ChemoCentryx initiated with a Buy at Stifel
12/22/20 Piper Sandler
Piper names ChemoCentryx a top pick for 2021, boosts target to $80
CALA Calithera Biosciences
$2.42 /

-0.065 (-2.62%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
HALO Halozyme
$42.36 /

-0.175 (-0.41%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
IMV IMV Inc.
$2.96 /

-0.235 (-7.36%)

12/29/20 Raymond James
Raymond James says IMV COVID plans look like 'red herring' to justify delay
07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
MORF Morphic
$60.76 /

-0.6 (-0.98%)

03/03/21 SVB Leerink
Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink
03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
MRNA Moderna
$131.52 /

-2 (-1.50%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
PGEN Precigen
$6.79 /

-0.24 (-3.41%)

03/02/21 B. Riley
Precigen price target raised to $14 from $10 at B. Riley Securities
02/25/21 Stifel
Precigen initiated with a Buy at Stifel
02/22/21 Wells Fargo
Precigen initiated with an Overweight at Wells Fargo
02/18/21
Fly Intel: Top five analyst initiations
QURE uniQure
$34.51 /

-1.41 (-3.93%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
04/01/21 Mizuho
uniQure upgraded to Buy from Neutral at Mizuho
03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
TCON Tracon Pharmaceuticals
$8.78 /

-0.18 (-2.01%)

04/01/21 JonesTrading
Tracon Pharmaceuticals initiated with a Buy at JonesTrading
02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
STRO Sutro Biopharma
$21.28 /

-1.6 (-6.99%)

01/28/21 Truist
Sutro Biopharma price target raised to $37 from $24 at Truist
12/02/20 Stifel
Sutro Biopharma initiated with a Buy at Stifel
11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
SGMO Sangamo
$11.24 /

-0.61 (-5.15%)

03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
09/08/20 BofA
Sangamo resumed with a Buy at BofA
RNA Avidity Biosciences
$23.58 /

-0.97 (-3.95%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
RGLS Regulus
$1.44 /

-0.04 (-2.70%)

05/04/20 H.C. Wainwright
Regulus price target lowered to $1.50 from $2 at H.C. Wainwright
ZIOP Ziopharm
$3.37 /

-0.045 (-1.32%)

03/12/21 Jefferies
Ziopharm downgraded to Hold from Buy at Jefferies
03/01/21
Fly Intel: Top five analyst downgrades
03/01/21 H.C. Wainwright
Ziopharm downgraded to Neutral from Buy at H.C. Wainwright
07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
ZIOP Ziopharm
$3.37 /

-0.045 (-1.32%)

TCON Tracon Pharmaceuticals
$8.78 /

-0.18 (-2.01%)

STRO Sutro Biopharma
$21.28 /

-1.6 (-6.99%)

SGMO Sangamo
$11.24 /

-0.61 (-5.15%)

RNA Avidity Biosciences
$23.58 /

-0.97 (-3.95%)

RGLS Regulus
$1.44 /

-0.04 (-2.70%)

QURE uniQure
$34.51 /

-1.41 (-3.93%)

PGEN Precigen
$6.79 /

-0.24 (-3.41%)

MRNA Moderna
$131.52 /

-2 (-1.50%)

MORF Morphic
$60.76 /

-0.6 (-0.98%)

HALO Halozyme
$42.36 /

-0.175 (-0.41%)

CLLS Cellectis
$19.28 /

-0.53 (-2.68%)

CCXI ChemoCentryx
$48.00 /

-0.79 (-1.62%)

CALA Calithera Biosciences
$2.42 /

-0.065 (-2.62%)

BLCM Bellicum Pharmaceuticals
$3.50 /

-0.12 (-3.31%)

BEAM Beam Therapeutics
$74.42 /

-2.26 (-2.95%)

AVRO Avrobio
$11.41 /

-0.3 (-2.56%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

  • 03
    Mar
  • 28
    Jan
  • 22
    Jan
  • 16
    Dec
  • 09
    Dec
  • 20
    Nov
  • 01
    Oct
  • 11
    Jun
  • 12
    Jun
  • 02
    Jun
  • 19
    May
  • 12
    May
  • 16
    Apr
MRNA Moderna
$131.52 /

-2 (-1.50%)

ZIOP Ziopharm
$3.37 /

-0.045 (-1.32%)

STRO Sutro Biopharma
$21.28 /

-1.6 (-6.99%)

QURE uniQure
$34.51 /

-1.41 (-3.93%)

PGEN Precigen
$6.79 /

-0.24 (-3.41%)

MRNA Moderna
$131.52 /

-2 (-1.50%)

MORF Morphic
$60.76 /

-0.6 (-0.98%)

HALO Halozyme
$42.36 /

-0.175 (-0.41%)

CCXI ChemoCentryx
$48.00 /

-0.79 (-1.62%)

CALA Calithera Biosciences
$2.42 /

-0.065 (-2.62%)

BLCM Bellicum Pharmaceuticals
$3.50 /

-0.12 (-3.31%)

AVRO Avrobio
$11.41 /

-0.3 (-2.56%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

TCON Tracon Pharmaceuticals
$8.78 /

-0.18 (-2.01%)

STRO Sutro Biopharma
$21.28 /

-1.6 (-6.99%)

SGMO Sangamo
$11.24 /

-0.61 (-5.15%)

PGEN Precigen
$6.79 /

-0.24 (-3.41%)

MRNA Moderna
$131.52 /

-2 (-1.50%)

BEAM Beam Therapeutics
$74.42 /

-2.26 (-2.95%)

Over a week ago
Conference/Events
Wells Fargo to hold a virtual conference » 04:55
04/07/21
04/07
04:55
04/07/21
04:55
ADAP

Adaptimmune

$5.26 /

-0.35 (-6.24%)

, AGTC

Applied Genetic

$4.74 /

-0.26 (-5.20%)

, BLCM

Bellicum Pharmaceuticals

$3.63 /

-0.08 (-2.16%)

, BEAM

Beam Therapeutics

$76.80 /

-3.74 (-4.64%)

, AVRO

Avrobio

$11.71 /

-0.89 (-7.06%)

, CLLS

Cellectis

$19.80 /

-1.01 (-4.85%)

, CCXI

ChemoCentryx

$48.79 /

-0.65 (-1.31%)

, CALA

Calithera Biosciences

$2.48 /

-0.02 (-0.80%)

, HALO

Halozyme

$42.53 /

-0.33 (-0.77%)

, IMV

IMV Inc.

$3.19 /

-0.03 (-0.93%)

, MORF

Morphic

$60.97 /

-0.38 (-0.62%)

, MRNA

Moderna

$133.51 /

+3.74 (+2.88%)

, PGEN

Precigen

$7.03 /

-0.63 (-8.22%)

, QURE

uniQure

$35.92 /

+0.19 (+0.53%)

, TCON

Tracon Pharmaceuticals

$8.96 /

+0.3 (+3.46%)

, STRO

Sutro Biopharma

$22.88 /

-0.87 (-3.66%)

, SGMO

Sangamo

$11.85 /

-0.79 (-6.25%)

, RNA

Avidity Biosciences

$24.54 /

-0.44 (-1.76%)

, RGLS

Regulus

$1.48 /

-0.03 (-1.99%)

, ZIOP

Ziopharm

$3.42 /

-0.27 (-7.33%)

Biotech Corporate Access…

Biotech Corporate Access Day Virtual Conference will be held on April 6-8.

ShowHide Related Items >><<
ZIOP Ziopharm
$3.42 /

-0.27 (-7.33%)

TCON Tracon Pharmaceuticals
$8.96 /

+0.3 (+3.46%)

STRO Sutro Biopharma
$22.88 /

-0.87 (-3.66%)

SGMO Sangamo
$11.85 /

-0.79 (-6.25%)

RNA Avidity Biosciences
$24.54 /

-0.44 (-1.76%)

RGLS Regulus
$1.48 /

-0.03 (-1.99%)

QURE uniQure
$35.92 /

+0.19 (+0.53%)

PGEN Precigen
$7.03 /

-0.63 (-8.22%)

MRNA Moderna
$133.51 /

+3.74 (+2.88%)

MORF Morphic
$60.97 /

-0.38 (-0.62%)

IMV IMV Inc.
$3.19 /

-0.03 (-0.93%)

HALO Halozyme
$42.53 /

-0.33 (-0.77%)

CLLS Cellectis
$19.80 /

-1.01 (-4.85%)

CCXI ChemoCentryx
$48.79 /

-0.65 (-1.31%)

CALA Calithera Biosciences
$2.48 /

-0.02 (-0.80%)

BLCM Bellicum Pharmaceuticals
$3.63 /

-0.08 (-2.16%)

BEAM Beam Therapeutics
$76.80 /

-3.74 (-4.64%)

AVRO Avrobio
$11.71 /

-0.89 (-7.06%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
BLCM Bellicum Pharmaceuticals
$3.63 /

-0.08 (-2.16%)

10/30/20
Fly Intel: Top five analyst downgrades
10/30/20 Ladenburg
Bellicum Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
10/30/20 Wells Fargo
Bellicum Pharmaceuticals downgraded to Equal Weight from Overweight at Wells Fargo
10/30/20 Wells Fargo
Bellicum downgraded to Equal Weight from Overweight at Wells Fargo
BEAM Beam Therapeutics
$76.80 /

-3.74 (-4.64%)

03/01/21 Barclays
Beam Therapeutics downgraded to Equal Weight from Overweight at Barclays
02/25/21 Wedbush
Beam Therapeutics price target raised to $112 from $42 at Wedbush
02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Wells Fargo
Beam Therapeutics initiated with an Overweight at Wells Fargo
AVRO Avrobio
$11.71 /

-0.89 (-7.06%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/09/21 Barclays
Avrobio initiated with an Overweight at Barclays
03/01/21 Stifel
Avrobio initiated with a Hold at Stifel
02/17/21 Mizuho
Avrobio selloff on Bluebird news a buying opportunity, says Mizuho
CLLS Cellectis
$19.80 /

-1.01 (-4.85%)

03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral from Outperform at Baird
08/19/20
Fly Intel: Top five analyst upgrades
CCXI ChemoCentryx
$48.79 /

-0.65 (-1.31%)

03/26/21 Piper Sandler
ChemoCentryx given FDA panel meeting on May 6, says Piper Sandler
03/02/21 H.C. Wainwright
ChemoCentryx price target raised to $101 from $83 at H.C. Wainwright
03/01/21 Stifel
ChemoCentryx initiated with a Buy at Stifel
12/22/20 Piper Sandler
Piper names ChemoCentryx a top pick for 2021, boosts target to $80
CALA Calithera Biosciences
$2.48 /

-0.02 (-0.80%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
HALO Halozyme
$42.53 /

-0.33 (-0.77%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
IMV IMV Inc.
$3.19 /

-0.03 (-0.93%)

12/29/20 Raymond James
Raymond James says IMV COVID plans look like 'red herring' to justify delay
07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
MORF Morphic
$60.97 /

-0.38 (-0.62%)

03/03/21 SVB Leerink
Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink
03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
MRNA Moderna
$133.51 /

+3.74 (+2.88%)

03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
02/26/21 Brookline
Moderna price target raised to $205 from $180 at Brookline
PGEN Precigen
$7.03 /

-0.63 (-8.22%)

03/02/21 B. Riley
Precigen price target raised to $14 from $10 at B. Riley Securities
02/25/21 Stifel
Precigen initiated with a Buy at Stifel
02/22/21 Wells Fargo
Precigen initiated with an Overweight at Wells Fargo
02/18/21
Fly Intel: Top five analyst initiations
QURE uniQure
$35.92 /

+0.19 (+0.53%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
04/01/21 Mizuho
uniQure upgraded to Buy from Neutral at Mizuho
03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
TCON Tracon Pharmaceuticals
$8.96 /

+0.3 (+3.46%)

04/01/21 JonesTrading
Tracon Pharmaceuticals initiated with a Buy at JonesTrading
02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
STRO Sutro Biopharma
$22.88 /

-0.87 (-3.66%)

01/28/21 Truist
Sutro Biopharma price target raised to $37 from $24 at Truist
12/02/20 Stifel
Sutro Biopharma initiated with a Buy at Stifel
11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
SGMO Sangamo
$11.85 /

-0.79 (-6.25%)

03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
09/08/20 BofA
Sangamo resumed with a Buy at BofA
RNA Avidity Biosciences
$24.54 /

-0.44 (-1.76%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
RGLS Regulus
$1.48 /

-0.03 (-1.99%)

05/04/20 H.C. Wainwright
Regulus price target lowered to $1.50 from $2 at H.C. Wainwright
ZIOP Ziopharm
$3.42 /

-0.27 (-7.33%)

03/12/21 Jefferies
Ziopharm downgraded to Hold from Buy at Jefferies
03/01/21
Fly Intel: Top five analyst downgrades
03/01/21 H.C. Wainwright
Ziopharm downgraded to Neutral from Buy at H.C. Wainwright
07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
ZIOP Ziopharm
$3.42 /

-0.27 (-7.33%)

TCON Tracon Pharmaceuticals
$8.96 /

+0.3 (+3.46%)

STRO Sutro Biopharma
$22.88 /

-0.87 (-3.66%)

SGMO Sangamo
$11.85 /

-0.79 (-6.25%)

RNA Avidity Biosciences
$24.54 /

-0.44 (-1.76%)

RGLS Regulus
$1.48 /

-0.03 (-1.99%)

QURE uniQure
$35.92 /

+0.19 (+0.53%)

PGEN Precigen
$7.03 /

-0.63 (-8.22%)

MRNA Moderna
$133.51 /

+3.74 (+2.88%)

MORF Morphic
$60.97 /

-0.38 (-0.62%)

HALO Halozyme
$42.53 /

-0.33 (-0.77%)

CLLS Cellectis
$19.80 /

-1.01 (-4.85%)

CCXI ChemoCentryx
$48.79 /

-0.65 (-1.31%)

CALA Calithera Biosciences
$2.48 /

-0.02 (-0.80%)

BLCM Bellicum Pharmaceuticals
$3.63 /

-0.08 (-2.16%)

BEAM Beam Therapeutics
$76.80 /

-3.74 (-4.64%)

AVRO Avrobio
$11.71 /

-0.89 (-7.06%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

  • 03
    Mar
  • 28
    Jan
  • 22
    Jan
  • 16
    Dec
  • 09
    Dec
  • 20
    Nov
  • 01
    Oct
  • 11
    Jun
  • 12
    Jun
  • 02
    Jun
  • 19
    May
  • 12
    May
  • 16
    Apr
MRNA Moderna
$133.51 /

+3.74 (+2.88%)

ZIOP Ziopharm
$3.42 /

-0.27 (-7.33%)

STRO Sutro Biopharma
$22.88 /

-0.87 (-3.66%)

QURE uniQure
$35.92 /

+0.19 (+0.53%)

PGEN Precigen
$7.03 /

-0.63 (-8.22%)

MRNA Moderna
$133.51 /

+3.74 (+2.88%)

MORF Morphic
$60.97 /

-0.38 (-0.62%)

HALO Halozyme
$42.53 /

-0.33 (-0.77%)

CCXI ChemoCentryx
$48.79 /

-0.65 (-1.31%)

CALA Calithera Biosciences
$2.48 /

-0.02 (-0.80%)

BLCM Bellicum Pharmaceuticals
$3.63 /

-0.08 (-2.16%)

AVRO Avrobio
$11.71 /

-0.89 (-7.06%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

TCON Tracon Pharmaceuticals
$8.96 /

+0.3 (+3.46%)

STRO Sutro Biopharma
$22.88 /

-0.87 (-3.66%)

SGMO Sangamo
$11.85 /

-0.79 (-6.25%)

PGEN Precigen
$7.03 /

-0.63 (-8.22%)

MRNA Moderna
$133.51 /

+3.74 (+2.88%)

BEAM Beam Therapeutics
$76.80 /

-3.74 (-4.64%)

Conference/Events
Wells Fargo to hold a virtual conference » 09:16
04/06/21
04/06
09:16
04/06/21
09:16
ADAP

Adaptimmune

$5.61 /

+0.105 (+1.91%)

, AGTC

Applied Genetic

$5.00 /

-0.225 (-4.31%)

, BLCM

Bellicum Pharmaceuticals

$3.68 /

+0.01 (+0.27%)

, BEAM

Beam Therapeutics

$80.57 /

+0.87 (+1.09%)

, AVRO

Avrobio

$12.60 /

+0.295 (+2.40%)

, CLLS

Cellectis

$20.84 /

+1.08 (+5.47%)

, CCXI

ChemoCentryx

$49.51 /

-1.28 (-2.52%)

, CALA

Calithera Biosciences

$2.50 /

+ (+0.00%)

, HALO

Halozyme

$42.81 /

+0.47 (+1.11%)

, IMV

IMV Inc.

$3.22 /

+0.04 (+1.26%)

, MORF

Morphic

$61.14 /

-3.91 (-6.01%)

, MRNA

Moderna

$129.83 /

-2.68 (-2.02%)

, PGEN

Precigen

$7.66 /

+0.685 (+9.82%)

, QURE

uniQure

$35.73 /

+1.64 (+4.81%)

, TCON

Tracon Pharmaceuticals

$8.66 /

+0.11 (+1.29%)

, STRO

Sutro Biopharma

$23.75 /

+0.31 (+1.32%)

, SGMO

Sangamo

$12.64 /

+0.355 (+2.89%)

, RNA

Avidity Biosciences

$25.26 /

+2.87 (+12.82%)

, RGLS

Regulus

$1.50 /

-0.075 (-4.76%)

, ZIOP

Ziopharm

$3.68 /

+0.04 (+1.10%)

Biotech Corporate Access…

Biotech Corporate Access Day Virtual Conference will be held on April 6-8.

ShowHide Related Items >><<
ZIOP Ziopharm
$3.68 /

+0.04 (+1.10%)

TCON Tracon Pharmaceuticals
$8.66 /

+0.11 (+1.29%)

STRO Sutro Biopharma
$23.75 /

+0.31 (+1.32%)

SGMO Sangamo
$12.64 /

+0.355 (+2.89%)

RNA Avidity Biosciences
$25.26 /

+2.87 (+12.82%)

RGLS Regulus
$1.50 /

-0.075 (-4.76%)

QURE uniQure
$35.73 /

+1.64 (+4.81%)

PGEN Precigen
$7.66 /

+0.685 (+9.82%)

MRNA Moderna
$129.83 /

-2.68 (-2.02%)

MORF Morphic
$61.14 /

-3.91 (-6.01%)

IMV IMV Inc.
$3.22 /

+0.04 (+1.26%)

HALO Halozyme
$42.81 /

+0.47 (+1.11%)

CLLS Cellectis
$20.84 /

+1.08 (+5.47%)

CCXI ChemoCentryx
$49.51 /

-1.28 (-2.52%)

CALA Calithera Biosciences
$2.50 /

+ (+0.00%)

BLCM Bellicum Pharmaceuticals
$3.68 /

+0.01 (+0.27%)

BEAM Beam Therapeutics
$80.57 /

+0.87 (+1.09%)

AVRO Avrobio
$12.60 /

+0.295 (+2.40%)

AGTC Applied Genetic
$5.00 /

-0.225 (-4.31%)

ADAP Adaptimmune
$5.61 /

+0.105 (+1.91%)

ADAP Adaptimmune
$5.61 /

+0.105 (+1.91%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$5.00 /

-0.225 (-4.31%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
BLCM Bellicum Pharmaceuticals
$3.68 /

+0.01 (+0.27%)

10/30/20
Fly Intel: Top five analyst downgrades
10/30/20 Ladenburg
Bellicum Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
10/30/20 Wells Fargo
Bellicum Pharmaceuticals downgraded to Equal Weight from Overweight at Wells Fargo
10/30/20 Wells Fargo
Bellicum downgraded to Equal Weight from Overweight at Wells Fargo
BEAM Beam Therapeutics
$80.57 /

+0.87 (+1.09%)

03/01/21 Barclays
Beam Therapeutics downgraded to Equal Weight from Overweight at Barclays
02/25/21 Wedbush
Beam Therapeutics price target raised to $112 from $42 at Wedbush
02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Wells Fargo
Beam Therapeutics initiated with an Overweight at Wells Fargo
AVRO Avrobio
$12.60 /

+0.295 (+2.40%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/09/21 Barclays
Avrobio initiated with an Overweight at Barclays
03/01/21 Stifel
Avrobio initiated with a Hold at Stifel
02/17/21 Mizuho
Avrobio selloff on Bluebird news a buying opportunity, says Mizuho
CLLS Cellectis
$20.84 /

+1.08 (+5.47%)

03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral from Outperform at Baird
08/19/20
Fly Intel: Top five analyst upgrades
CCXI ChemoCentryx
$49.51 /

-1.28 (-2.52%)

03/26/21 Piper Sandler
ChemoCentryx given FDA panel meeting on May 6, says Piper Sandler
03/02/21 H.C. Wainwright
ChemoCentryx price target raised to $101 from $83 at H.C. Wainwright
03/01/21 Stifel
ChemoCentryx initiated with a Buy at Stifel
12/22/20 Piper Sandler
Piper names ChemoCentryx a top pick for 2021, boosts target to $80
CALA Calithera Biosciences
$2.50 /

+ (+0.00%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
HALO Halozyme
$42.81 /

+0.47 (+1.11%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
IMV IMV Inc.
$3.22 /

+0.04 (+1.26%)

12/29/20 Raymond James
Raymond James says IMV COVID plans look like 'red herring' to justify delay
07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
MORF Morphic
$61.14 /

-3.91 (-6.01%)

03/03/21 SVB Leerink
Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink
03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
MRNA Moderna
$129.83 /

-2.68 (-2.02%)

03/15/21 Piper Sandler
Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
02/26/21 Brookline
Moderna price target raised to $205 from $180 at Brookline
PGEN Precigen
$7.66 /

+0.685 (+9.82%)

03/02/21 B. Riley
Precigen price target raised to $14 from $10 at B. Riley Securities
02/25/21 Stifel
Precigen initiated with a Buy at Stifel
02/22/21 Wells Fargo
Precigen initiated with an Overweight at Wells Fargo
02/18/21
Fly Intel: Top five analyst initiations
QURE uniQure
$35.73 /

+1.64 (+4.81%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
04/01/21 Mizuho
uniQure upgraded to Buy from Neutral at Mizuho
03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
TCON Tracon Pharmaceuticals
$8.66 /

+0.11 (+1.29%)

04/01/21 JonesTrading
Tracon Pharmaceuticals initiated with a Buy at JonesTrading
02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
STRO Sutro Biopharma
$23.75 /

+0.31 (+1.32%)

01/28/21 Truist
Sutro Biopharma price target raised to $37 from $24 at Truist
12/02/20 Stifel
Sutro Biopharma initiated with a Buy at Stifel
11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
SGMO Sangamo
$12.64 /

+0.355 (+2.89%)

03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
09/08/20 BofA
Sangamo resumed with a Buy at BofA
RNA Avidity Biosciences
$25.26 /

+2.87 (+12.82%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
RGLS Regulus
$1.50 /

-0.075 (-4.76%)

05/04/20 H.C. Wainwright
Regulus price target lowered to $1.50 from $2 at H.C. Wainwright
ZIOP Ziopharm
$3.68 /

+0.04 (+1.10%)

03/12/21 Jefferies
Ziopharm downgraded to Hold from Buy at Jefferies
03/01/21
Fly Intel: Top five analyst downgrades
03/01/21 H.C. Wainwright
Ziopharm downgraded to Neutral from Buy at H.C. Wainwright
07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
ZIOP Ziopharm
$3.68 /

+0.04 (+1.10%)

TCON Tracon Pharmaceuticals
$8.66 /

+0.11 (+1.29%)

STRO Sutro Biopharma
$23.75 /

+0.31 (+1.32%)

SGMO Sangamo
$12.64 /

+0.355 (+2.89%)

RNA Avidity Biosciences
$25.26 /

+2.87 (+12.82%)

RGLS Regulus
$1.50 /

-0.075 (-4.76%)

QURE uniQure
$35.73 /

+1.64 (+4.81%)

PGEN Precigen
$7.66 /

+0.685 (+9.82%)

MRNA Moderna
$129.83 /

-2.68 (-2.02%)

MORF Morphic
$61.14 /

-3.91 (-6.01%)

HALO Halozyme
$42.81 /

+0.47 (+1.11%)

CLLS Cellectis
$20.84 /

+1.08 (+5.47%)

CCXI ChemoCentryx
$49.51 /

-1.28 (-2.52%)

CALA Calithera Biosciences
$2.50 /

+ (+0.00%)

BLCM Bellicum Pharmaceuticals
$3.68 /

+0.01 (+0.27%)

BEAM Beam Therapeutics
$80.57 /

+0.87 (+1.09%)

AVRO Avrobio
$12.60 /

+0.295 (+2.40%)

AGTC Applied Genetic
$5.00 /

-0.225 (-4.31%)

ADAP Adaptimmune
$5.61 /

+0.105 (+1.91%)

  • 03
    Mar
  • 28
    Jan
  • 22
    Jan
  • 16
    Dec
  • 09
    Dec
  • 20
    Nov
  • 01
    Oct
  • 11
    Jun
  • 12
    Jun
  • 02
    Jun
  • 19
    May
  • 12
    May
  • 16
    Apr
MRNA Moderna
$129.83 /

-2.68 (-2.02%)

ZIOP Ziopharm
$3.68 /

+0.04 (+1.10%)

STRO Sutro Biopharma
$23.75 /

+0.31 (+1.32%)

QURE uniQure
$35.73 /

+1.64 (+4.81%)

PGEN Precigen
$7.66 /

+0.685 (+9.82%)

MRNA Moderna
$129.83 /

-2.68 (-2.02%)

MORF Morphic
$61.14 /

-3.91 (-6.01%)

HALO Halozyme
$42.81 /

+0.47 (+1.11%)

CCXI ChemoCentryx
$49.51 /

-1.28 (-2.52%)

CALA Calithera Biosciences
$2.50 /

+ (+0.00%)

BLCM Bellicum Pharmaceuticals
$3.68 /

+0.01 (+0.27%)

AVRO Avrobio
$12.60 /

+0.295 (+2.40%)

AGTC Applied Genetic
$5.00 /

-0.225 (-4.31%)

TCON Tracon Pharmaceuticals
$8.66 /

+0.11 (+1.29%)

STRO Sutro Biopharma
$23.75 /

+0.31 (+1.32%)

SGMO Sangamo
$12.64 /

+0.355 (+2.89%)

PGEN Precigen
$7.66 /

+0.685 (+9.82%)

MRNA Moderna
$129.83 /

-2.68 (-2.02%)

BEAM Beam Therapeutics
$80.57 /

+0.87 (+1.09%)

Conference/Events
JPMorgan SMID cap biotech analyst holds analyst/industry conference call » 12:25
03/24/21
03/24
12:25
03/24/21
12:25
HALO

Halozyme

$42.64 /

-0.47 (-1.09%)

SMid Cap Biotech Analyst…

SMid Cap Biotech Analyst Fye holds a conference call with CEO Torley on March 24 at 1 pm hosted by JPMorgan.

ShowHide Related Items >><<
HALO Halozyme
$42.64 /

-0.47 (-1.09%)

HALO Halozyme
$42.64 /

-0.47 (-1.09%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HALO Halozyme
$42.64 /

-0.47 (-1.09%)

HALO Halozyme
$42.64 /

-0.47 (-1.09%)

Conference/Events
JPMorgan SMID cap biotech analyst holds analyst/industry conference call » 10:56
03/24/21
03/24
10:56
03/24/21
10:56
HALO

Halozyme

$42.57 /

-0.54 (-1.25%)

SMid Cap Biotech Analyst…

SMid Cap Biotech Analyst Fye holds a conference call with CEO Torley on March 24 at 1 pm hosted by JPMorgan.

ShowHide Related Items >><<
HALO Halozyme
$42.57 /

-0.54 (-1.25%)

HALO Halozyme
$42.57 /

-0.54 (-1.25%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HALO Halozyme
$42.57 /

-0.54 (-1.25%)

HALO Halozyme
$42.57 /

-0.54 (-1.25%)

Over a month ago
Conference/Events
Halozyme management to meet virtually with Cantor Fitzgerald » 04:55
02/26/21
02/26
04:55
02/26/21
04:55
HALO

Halozyme

$47.35 /

-4.08 (-7.93%)

Virtual Meeting to be…

Virtual Meeting to be held on February 26 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
HALO Halozyme
$47.35 /

-4.08 (-7.93%)

HALO Halozyme
$47.35 /

-4.08 (-7.93%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HALO Halozyme
$47.35 /

-4.08 (-7.93%)

HALO Halozyme
$47.35 /

-4.08 (-7.93%)

Conference/Events
Halozyme management to meet virtually with Cantor Fitzgerald » 11:17
02/25/21
02/25
11:17
02/25/21
11:17
HALO

Halozyme

$47.49 /

-3.94 (-7.66%)

Virtual Meeting to be…

Virtual Meeting to be held on February 26 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
HALO Halozyme
$47.49 /

-3.94 (-7.66%)

HALO Halozyme
$47.49 /

-3.94 (-7.66%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HALO Halozyme
$47.49 /

-3.94 (-7.66%)

HALO Halozyme
$47.49 /

-3.94 (-7.66%)

On The Fly
Fly Intel: After-Hours Movers » 18:51
02/23/21
02/23
18:51
02/23/21
18:51
UPWK

Upwork

$51.76 /

+0.29 (+0.56%)

, MCFE

McAfee

$19.41 /

-0.05 (-0.26%)

, ESPR

Esperion

$27.88 /

-0.69 (-2.42%)

, SPT

Sprout Social

$67.81 /

-2.49 (-3.54%)

, PEN

Penumbra

$280.77 /

+0.9 (+0.32%)

, NBR

Nabors Industries

$88.31 /

-1.05 (-1.18%)

, GTY

Getty Realty

$28.77 /

+0.58 (+2.06%)

, CSGP

CoStar Group

$866.51 /

-9.17 (-1.05%)

, FLS

Flowserve

$39.49 /

+0.32 (+0.82%)

, GTES

Gates Industrial

$17.89 /

+0.72 (+4.19%)

, XPER

Xperi

$22.02 /

+0.3 (+1.38%)

, MTDR

Matador

$21.31 /

+1.05 (+5.18%)

, HALO

Halozyme

$47.29 /

-1.43 (-2.94%)

, HT

Hersha Hospitality

$11.14 /

+0.47 (+4.40%)

, SQ

Square

$256.62 /

-11.655 (-4.34%)

, VRSK

Verisk Analytics

$185.13 /

-1.14 (-0.61%)

, PUMP

ProPetro Holding

$10.38 /

+0.115 (+1.12%)

, INTU

Intuit

$398.00 /

-3.58 (-0.89%)

, PXD

Pioneer Natural

$145.00 /

+5.635 (+4.04%)

, GME

GameStop

$44.92 /

-0.53 (-1.17%)

Check out this evening's…

ShowHide Related Items >><<
XPER Xperi
$22.02 /

+0.3 (+1.38%)

VRSK Verisk Analytics
$185.13 /

-1.14 (-0.61%)

UPWK Upwork
$51.76 /

+0.29 (+0.56%)

SQ Square
$256.62 /

-11.655 (-4.34%)

SPT Sprout Social
$67.81 /

-2.49 (-3.54%)

PXD Pioneer Natural
$145.00 /

+5.635 (+4.04%)

PUMP ProPetro Holding
$10.38 /

+0.115 (+1.12%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

NBR Nabors Industries
$88.31 /

-1.05 (-1.18%)

MTDR Matador
$21.31 /

+1.05 (+5.18%)

MCFE McAfee
$19.41 /

-0.05 (-0.26%)

INTU Intuit
$398.00 /

-3.58 (-0.89%)

HT Hersha Hospitality
$11.14 /

+0.47 (+4.40%)

HALO Halozyme
$47.29 /

-1.43 (-2.94%)

GTY Getty Realty
$28.77 /

+0.58 (+2.06%)

GTES Gates Industrial
$17.89 /

+0.72 (+4.19%)

GME GameStop
$44.92 /

-0.53 (-1.17%)

FLS Flowserve
$39.49 /

+0.32 (+0.82%)

ESPR Esperion
$27.88 /

-0.69 (-2.42%)

CSGP CoStar Group
$866.51 /

-9.17 (-1.05%)

UPWK Upwork
$51.76 /

+0.29 (+0.56%)

02/16/21 BTIG
Upwork price target raised to $68 from $42 at BTIG
01/12/21 Citi
Upwork upgraded to Buy from Neutral at Citi
01/12/21 Citi
Fiverr price target raised to $270 from $185 at Citi
01/11/21
Fly Intel: Top five analyst downgrades
MCFE McAfee
$19.41 /

-0.05 (-0.26%)

02/17/21 Stifel
McAfee initiated with a Hold at Stifel
02/02/21 Morgan Stanley
McAfee price target raised to $27, called a top pick at Morgan Stanley
01/12/21 Mizuho
McAfee price target raised to $25 from $24 at Mizuho
12/03/20 DA Davidson
Crowdstrike price target raised to $185 from $160 at DA Davidson
ESPR Esperion
$27.88 /

-0.69 (-2.42%)

02/12/21 Jefferies
Jefferies downgrades Esperion to Hold as launches will take time
02/12/21 Jefferies
Esperion downgraded to Hold from Buy at Jefferies
02/09/21
Fly Intel: Top five analyst downgrades
02/09/21 Goldman Sachs
Esperion downgraded to Sell from Neutral at Goldman Sachs
SPT Sprout Social
$67.81 /

-2.49 (-3.54%)

01/19/21 BTIG
Sprout Social price target raised to $71 from $55 at BTIG
11/17/20 Morgan Stanley
Morgan Stanley downgrades Sprout Social to Equal Weight as valuation gap narrows
11/17/20 Morgan Stanley
Sprout Social downgraded to Equal Weight from Overweight at Morgan Stanley
11/10/20 BTIG
Sprout Social price target raised to $55 from $48 at BTIG
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

12/16/20
Fly Intel: Top five analyst downgrades
12/16/20 Wells Fargo
Penumbra price target lowered to $215 from $265 at Wells Fargo
12/16/20 Canaccord
Penumbra price target lowered to $204 from $292 at Canaccord
12/16/20 Citi
Citi keeps Buy rating on Penumbra, says recall 'clearning event'
NBR Nabors Industries
$88.31 /

-1.05 (-1.18%)

08/18/20 Citi
Nabors Industries downgraded to Sell from Neutral at Citi
08/12/20 Goldman Sachs
Nabors Industries downgraded to Sell from Neutral at Goldman Sachs
08/03/20 Barclays
Barclays upgrades Nabors to Equal Weight on improved earnings outlook
08/03/20 Barclays
Nabors Industries upgraded to Equal Weight from Underweight at Barclays
GTY Getty Realty
$28.77 /

+0.58 (+2.06%)

10/22/20 JPMorgan
Getty Realty upgraded to Neutral on 'better footing' at JPMorgan
10/22/20 JPMorgan
Getty Realty upgraded to Neutral from Underweight at JPMorgan
06/08/20 JMP Securities
Getty Realty resumed with an Outperform at JMP Securities
CSGP CoStar Group
$866.51 /

-9.17 (-1.05%)

02/04/21 Stephens
CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens
12/22/20 JMP Securities
RealPage price target raised to $101 from $80 at JMP Securities
11/23/20 Wells Fargo
CoStar Group price target raised to $990 from $915 at Wells Fargo
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
FLS Flowserve
$39.49 /

+0.32 (+0.82%)

01/04/21 Credit Suisse
Flowserve downgraded to Neutral from Outperform at Credit Suisse
12/15/20
Fly Intel: Top five analyst upgrades
12/15/20 Stifel
Flowserve upgraded to Buy at Stifel ahead of expected multiple expansion
12/15/20 Stifel
Flowserve upgraded to Buy from Hold at Stifel
GTES Gates Industrial
$17.89 /

+0.72 (+4.19%)

02/22/21 RBC Capital
RBC upgrades Gates Industrial to Outperform on positive earnings inflection
02/22/21 RBC Capital
Gates Industrial upgraded to Outperform from Sector Perform at RBC Capital
02/09/21 Barclays
Gates Industrial price target raised to $18 from $16 at Barclays
02/09/21 Citi
Gates Industrial price target raised to $22 from $18 at Citi
XPER Xperi
$22.02 /

+0.3 (+1.38%)

11/16/20 B. Riley
Xperi shares can nearly double from current levels, says B. Riley Securities
11/10/20 BWS Financial
Xperi settlement paves way for $26 share price, says BWS Financial
09/28/20 BWS Financial
Walmart availability could mean Xperi ready for mass market, says BWS Financial
08/24/20 BWS Financial
Xperi initiated with a Buy at BWS Financial
MTDR Matador
$21.31 /

+1.05 (+5.18%)

02/09/21 MKM Partners
Matador downgraded to Neutral from Buy at MKM Partners
02/09/21 MKM Partners
Matador downgraded to Neutral from Buy at MKM Partners
12/30/20 Truist
Matador price target raised to $16 from $13 at Truist
12/17/20 BMO Capital
Matador upgraded to Outperform from Market Perform at BMO Capital
HALO Halozyme
$47.29 /

-1.43 (-2.94%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HT Hersha Hospitality
$11.14 /

+0.47 (+4.40%)

12/10/20 Wells Fargo
Hersha Hospitality upgraded to Equal Weight with $9 target at Wells Fargo
12/02/20 B. Riley
Hersha Hospitality price target raised to $8 from $6 at B. Riley Securities
06/22/20 Barclays
Hersha Hospitality price target raised to $6 from $3 at Barclays
06/17/20 DA Davidson
Hersha Hospitality upgraded to Neutral from Underperform at DA Davidson
SQ Square
$256.62 /

-11.655 (-4.34%)

02/22/21 Barclays
Square price target raised to $320 from $260 at Barclays
02/22/21 Mizuho
Mizuho ups Square target to $380, calls shares 'simply undervalued'
02/19/21 Evercore ISI
Evercore ISI 'pounding table' on Square ahead of expected earnings beat
02/17/21 Deutsche Bank
Square price target raised to $330 from $255 at Deutsche Bank
VRSK Verisk Analytics
$185.13 /

-1.14 (-0.61%)

12/17/20 Barclays
Verisk Analytics price target raised to $250 from $220 at Barclays
12/01/20 Truist
Verisk Analytics upgraded to Buy from Hold at Truist
12/01/20 Truist
Verisk Analytics upgraded to Buy from Hold at Truist
11/09/20 BMO Capital
Verisk Analytics price target raised to $196 from $181 at BMO Capital
PUMP ProPetro Holding
$10.38 /

+0.115 (+1.12%)

01/25/21 B. Riley
ProPetro Holding price target raised to $9.50 from $6.50 at B. Riley Securities
01/11/21 Wolfe Research
ProPetro Holding downgraded to Underperform from Peer Perform at Wolfe Research
12/24/20 Piper Sandler
ProPetro Holding price target raised to $8 from $5 at Piper Sandler
12/18/20 JPMorgan
ProPetro Holding price target raised to $10 from $6 at JPMorgan
INTU Intuit
$398.00 /

-3.58 (-0.89%)

02/23/21
Fly Intel: Top five analyst upgrades
02/23/21 Evercore ISI
Intuit upgraded to Outperform from In Line at Evercore ISI
02/23/21 Evercore ISI
Intuit upgraded to Outperform from In Line at Evercore ISI
02/19/21 Barclays
Intuit price target raised to $480 from $455 at Barclays
PXD Pioneer Natural
$145.00 /

+5.635 (+4.04%)

02/08/21 Morgan Stanley
Pioneer Natural resumed with an Equal Weight at Morgan Stanley
01/19/21 Goldman Sachs
Pioneer Natural reinstated with a Buy at Goldman Sachs
01/15/21 Citi
Pioneer Natural price target raised to $154 from $130 at Citi
01/14/21 Barclays
Pioneer Natural price target raised to $153 from $151 at Barclays
GME GameStop
$44.92 /

-0.53 (-1.17%)

02/11/21 GLJ Research
GLJ calls end to Reddit-driven Tilray rally, predicts 100% share downside
02/01/21 Mizuho
Square benefited most from traders leaving Robinhood, says Mizuho
01/27/21 BofA
With GameStop shares trading at $213.50, BofA raises price target to $10
01/25/21 KeyBanc
Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc
XPER Xperi
$22.02 /

+0.3 (+1.38%)

VRSK Verisk Analytics
$185.13 /

-1.14 (-0.61%)

UPWK Upwork
$51.76 /

+0.29 (+0.56%)

SQ Square
$256.62 /

-11.655 (-4.34%)

SPT Sprout Social
$67.81 /

-2.49 (-3.54%)

PXD Pioneer Natural
$145.00 /

+5.635 (+4.04%)

PUMP ProPetro Holding
$10.38 /

+0.115 (+1.12%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

NBR Nabors Industries
$88.31 /

-1.05 (-1.18%)

MTDR Matador
$21.31 /

+1.05 (+5.18%)

MCFE McAfee
$19.41 /

-0.05 (-0.26%)

INTU Intuit
$398.00 /

-3.58 (-0.89%)

HT Hersha Hospitality
$11.14 /

+0.47 (+4.40%)

HALO Halozyme
$47.29 /

-1.43 (-2.94%)

GTY Getty Realty
$28.77 /

+0.58 (+2.06%)

GTES Gates Industrial
$17.89 /

+0.72 (+4.19%)

GME GameStop
$44.92 /

-0.53 (-1.17%)

FLS Flowserve
$39.49 /

+0.32 (+0.82%)

ESPR Esperion
$27.88 /

-0.69 (-2.42%)

CSGP CoStar Group
$866.51 /

-9.17 (-1.05%)

  • 26
    Feb
  • 09
    Dec
  • 22
    Oct
  • 13
    Aug
  • 28
    May
  • 21
    May
UPWK Upwork
$51.76 /

+0.29 (+0.56%)

SQ Square
$256.62 /

-11.655 (-4.34%)

PXD Pioneer Natural
$145.00 /

+5.635 (+4.04%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

NBR Nabors Industries
$88.31 /

-1.05 (-1.18%)

INTU Intuit
$398.00 /

-3.58 (-0.89%)

GME GameStop
$44.92 /

-0.53 (-1.17%)

CSGP CoStar Group
$866.51 /

-9.17 (-1.05%)

XPER Xperi
$22.02 /

+0.3 (+1.38%)

UPWK Upwork
$51.76 /

+0.29 (+0.56%)

SQ Square
$256.62 /

-11.655 (-4.34%)

SPT Sprout Social
$67.81 /

-2.49 (-3.54%)

PXD Pioneer Natural
$145.00 /

+5.635 (+4.04%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

NBR Nabors Industries
$88.31 /

-1.05 (-1.18%)

MTDR Matador
$21.31 /

+1.05 (+5.18%)

MCFE McAfee
$19.41 /

-0.05 (-0.26%)

INTU Intuit
$398.00 /

-3.58 (-0.89%)

HALO Halozyme
$47.29 /

-1.43 (-2.94%)

GME GameStop
$44.92 /

-0.53 (-1.17%)

ESPR Esperion
$27.88 /

-0.69 (-2.42%)

CSGP CoStar Group
$866.51 /

-9.17 (-1.05%)

UPWK Upwork
$51.76 /

+0.29 (+0.56%)

SQ Square
$256.62 /

-11.655 (-4.34%)

PXD Pioneer Natural
$145.00 /

+5.635 (+4.04%)

NBR Nabors Industries
$88.31 /

-1.05 (-1.18%)

MTDR Matador
$21.31 /

+1.05 (+5.18%)

MCFE McAfee
$19.41 /

-0.05 (-0.26%)

INTU Intuit
$398.00 /

-3.58 (-0.89%)

GME GameStop
$44.92 /

-0.53 (-1.17%)

FLS Flowserve
$39.49 /

+0.32 (+0.82%)

ESPR Esperion
$27.88 /

-0.69 (-2.42%)

Syndicate
Halozyme files to sell $500M of convertible notes due 2027  16:15
02/23/21
02/23
16:15
02/23/21
16:15
HALO

Halozyme

$47.29 /

-1.43 (-2.94%)

 
ShowHide Related Items >><<
HALO Halozyme
$47.29 /

-1.43 (-2.94%)

HALO Halozyme
$47.29 /

-1.43 (-2.94%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HALO Halozyme
$47.29 /

-1.43 (-2.94%)

HALO Halozyme
$47.29 /

-1.43 (-2.94%)

Earnings
Halozyme sees FY21 GAAP EPS $1.40-$1.55, consensus $1.70 » 16:07
02/23/21
02/23
16:07
02/23/21
16:07
HALO

Halozyme

$47.76 /

-0.96 (-1.97%)

Sees FY21 revenue…

Sees FY21 revenue $375M-$395M, consensus $400.15M. FY21 revenue outlook represents year-over-year growth of 40%-48%, with revenues from royalties projected to approximately double versus 2020; Operating Income of $215M-$235M, representing year-over-year growth of 49%-63%. The Company plans to repurchase up to $125M in common stock during 2021 as part of the $550M three-year share repurchase plan authorized by Halozyme's board of directors in 2019. The amount and timing of shares to be repurchased in 2021 will be subject to a variety of factors including market conditions, other business considerations and applicable legal requirements.

ShowHide Related Items >><<
HALO Halozyme
$47.76 /

-0.96 (-1.97%)

HALO Halozyme
$47.76 /

-0.96 (-1.97%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
HALO Halozyme
$47.76 /

-0.96 (-1.97%)

HALO Halozyme
$47.76 /

-0.96 (-1.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.